(Q45008557)

8 December 2017

title

GD3 expression by cultured human tumor cells of neuroectodermal origin (English)

1 reference

8 December 2017

6

D D Bigner

1 reference

8 December 2017

X He

1

1 reference

8 December 2017

C J Wikstrand

2

1 reference

8 December 2017

P Fredman

3

1 reference

8 December 2017

J E Månsson

4

1 reference

8 December 2017

L Svennerholm

5

1 reference

8 December 2017

publication date

1 January 1989

1 reference

8 December 2017

published in

Acta Neuropathologica

1 reference

8 December 2017

volume

79

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

317-325

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00294668

8 December 2017

exact match

0 references

cites work

Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody

1 reference

12 December 2020

Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues

1 reference

12 December 2020

Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma

1 reference

12 December 2020

Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.

1 reference

12 December 2020

Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies

1 reference

12 December 2020

A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.

1 reference

12 December 2020

In vitro biosynthesis of the tetrasialoganglioside GQ1b.

1 reference

12 December 2020

Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro

1 reference

12 December 2020

Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis

1 reference

12 December 2020

Gangliosides of human cerebral astrocytomas.

1 reference

12 December 2020

Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line.

1 reference

12 December 2020

Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method

1 reference

12 December 2020

An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.

1 reference

12 December 2020

Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts

1 reference

12 December 2020

Gangliosides and neutral glycosphingolipids in human brain tumors: specificity and their significance.

1 reference

12 December 2020

Surface antigenic characteristics of human glial brain tumor cells

1 reference

12 December 2020

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

12 December 2020

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

1 reference

12 December 2020

Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth.

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Gangliosides of human melanoma: altered expression in vivo and in vitro

1 reference

12 December 2020

Potential ganglioside antigens associated with human gliomas.

1 reference

12 December 2020

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1 reference

12 December 2020

Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside

1 reference

12 December 2020

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

12 December 2020

Glycosphingolipids as tumor-associated and differentiation markers.

1 reference

12 December 2020

Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis

1 reference

12 December 2020

Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

1 reference

12 December 2020

Correlation between ganglioside distribution and histological grading of human astrocytomas.

1 reference

12 December 2020

A procedure for the quantitative isolation of brain gangliosides

1 reference

12 December 2020

Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides

1 reference

12 December 2020

Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives

1 reference

12 December 2020

A cell-surface antigen which is present in the ganglioside fraction and shared by human melanomas

1 reference

12 December 2020

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Expression of GD2 ganglioside by untreated primary human neuroblastomas

1 reference

12 December 2020

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00294668

1 reference

Dimensions Publication ID

8 December 2017

1030902598

0 references

1 reference